Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Syracuse, New York 13202


Purpose:

Researchers have previously demonstrated loss of heterozygosity in a region on chromosome 18q, associated with osteogenic sarcomas in bone affected by Paget's disease. The loci used in this study are specifically described by those authors as showing loss of heterozygosity in 6 of 7 affected families.


Study summary:

As above, no additional information


Criteria:

Inclusion Criteria: - This is a familial study therefore the only inclusion/exclusion criteria would be that subjects must be a blood relative and over the age of 18. - The subjects are proband and father along with unaffected blood relatives. Their peripheral blood will act as a control and provide information to delineate the inheritance from the father, as seen in the son. Exclusion Criteria: - Not part of the family


NCT ID:

NCT00615628


Primary Contact:

Principal Investigator
Timothy A Damron, MD
State University of New York - Upstate Medical University


Backup Contact:

N/A


Location Contact:

Syracuse, New York 13202
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.